RegMedNet at Translational Opportunities in Stem Cell Research (ISSCR)
Thermo Fisher Scientific and the Cell and Gene Therapy Catapult collaborate to optimize advanced therapy supply chain
Commercialization of cell therapies – biopreservation’s make or break impact: an interview with Mike Rice
Scaling human pluripotent stem cell expansion and differentiation: are cell factories becoming a reality?
Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products
The translation of cell-based therapies: clinical landscape and manufacturing challenges
Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction
Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use